Sorry, you need to enable JavaScript to visit this website.

Kaynes Semicon Private Limited - Strategic investment by US Technology International Private Limited

Submitted by kcoadmin on Thu, 10/09/2025 - 11:27

Khaitan & Co advised Kaynes Semicon Pvt Ltd (Company) and its controlling shareholder (i.e., Kaynes Technology India Ltd) on the strategic investment by US Technology International Pvt Ltd (UST) for minority stake in the Company. 

This strategic partnership between the Company and UST is expected to play a key role in shaping up the future of semiconductor engineering in India and making India a leading semiconductor hub.

Initial public offering of TruAlt Bioenergy Limited

Submitted by kcoadmin on Thu, 10/09/2025 - 11:17

Khaitan & Co advised TruAlt Bioenergy Ltd in relation to their initial public offering of equity shares aggregating approximately INR 83,928 lakhs, which comprised of issuance of (i) a fresh issue of equity shares aggregating to INR 75,000 lakhs; and (ii) offer for sale by the Promoter Group Selling Shareholders aggregating to INR 8,928 lakhs. The IPO was oversubscribed by 74.50 times, with the retail investors’ portion being oversubscribed by 10.62 times, the QIB portion being oversubscribed by 165.15 times and the NII portion being oversubscribed by 102.67 times.  

Sterlite Electric Limited - Filing of the DRHP for the proposed IPO

Submitted by kcoadmin on Thu, 10/09/2025 - 11:05

Khaitan & Co acted as legal counsel the book running lead managers (Axis Capital Ltd, Motilal Oswal Investment Advisors Ltd and Nuvama Wealth Management Ltd) as to Indian law in connection with the draft red herring prospectus filed by Sterlite Electric Ltd (formerly known as Sterlite Power Transmission Ltd) in relation to its proposed initial public offering of equity shares, consisting of a fresh issue and an offer for sale aggregating up to INR 1500 crores.

Investment by Kedaara Group in Axtria

Submitted by kcoadmin on Tue, 10/07/2025 - 12:19

Khaitan & Co  advised Kedaara Capital (“Kedaara”) in relation to its investment into Axtria, Inc. and its subsidiaries (“Axtria”), a leading Agentic AI-first data analytics and cloud software company serving the global life sciences industry, across the commercial and clinical spectrum. Structured as a combination of secondary investment and company-sponsored buyback, the transaction delivers total liquidity of USD 240 million.